Pyrazole-based ion-channel inhibitors are highly selective drugs with potential to cure various diseases. Employing high-temperature reaction conditions in sealed vials the multistep synthesis can be significantly enhanced resulting in short time reaction steps.
PMI falls as manufacturers feel the squeeze
17 months or two and a half years - which is it?